154 results on '"Chen, Wuyan"'
Search Results
2. Natural product piperine alleviates experimental allergic encephalomyelitis in mice by targeting dihydroorotate dehydrogenase
3. Recommendations for risk allele evidence curation, classification, and reporting from the ClinGen Low Penetrance/Risk Allele Working Group
4. SS31 attenuates oxidative stress and neuronal apoptosis in early brain injury following subarachnoid hemorrhage possibly by the mitochondrial pathway
5. Asynchronous Page-Rank Computation in Spark
6. Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians
7. Genetics of Congenital Adrenal Hyperplasia
8. Design, synthesis and biological evaluation of tasiamide B derivatives as BACE1 inhibitors
9. P145: Microcephaly in atypical Silver-Russell syndrome caused by defects in PLAG1
10. Discovery of potent N-(isoxazol-5-yl)amides as HSP90 inhibitors
11. Asynchronous Page-Rank Computation in Spark
12. Discovery of pyrazole as C-terminus of selective BACE1 inhibitors
13. Broadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia
14. Complement component 4 copy number variation and CYP21A2 genotype associations in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
15. Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein
16. Tenascin-X Haploinsufficiency Associated with Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia
17. Significant Association Between the Genetic Variations in the 5′ End of the N-Methyl-D-Aspartate Receptor Subunit Gene GRIN1 and Schizophrenia
18. A Novel Intronic Pathogenic Variant in STAR With a Dominant Negative Mechanism Causes Attenuated Lipoid Congenital Adrenal Hyperplasia
19. Clinical Utility of Genetic Testing in the Precision Diagnosis and Management of Pediatric Patients with Kidney and Urinary Tract Diseases
20. Comprehensive Genetic Analysis of 182 Unrelated Families with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
21. A TNXB splice donor site variant as a cause of hypermobility type Ehlers–Danlos syndrome in patients with congenital adrenal hyperplasia
22. Clinical utility of genetic and genomic testing in the precision diagnosis and management of pediatric patients with kidney and urinary tract diseases
23. The Phenotypic Spectrum of Contiguous Deletion of CYP21A2 and Tenascin XB: Quadricuspid Aortic Valve and Other Midline Defects
24. Association of the carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase gene with schizophrenia in the Chinese Han population
25. A case–control study provides evidence of association for a functional polymorphism −197C/G in XBP1 to schizophrenia and suggests a sex-dependent effect
26. Structure-Aided Identification and Optimization of Tetrahydro-isoquinolines as Novel PDE4 Inhibitors Leading to Discovery of an Effective Antipsoriasis Agent
27. A TNXB splice donor site variant as a cause of hypermobility type Ehlers–Danlos syndrome in patients with congenital adrenal hyperplasia.
28. Pharmacological inhibition of dihydroorotate dehydrogenase induces apoptosis and differentiation in acute myeloid leukemia cells
29. Identification of a new series of potent diphenol HSP90 inhibitors by fragment merging and structure-based optimization
30. Comprehensive Mutation Analysis of the CYP21A2 Gene: An Efficient Multistep Approach to the Molecular Diagnosis of Congenital Adrenal Hyperplasia
31. Ehlers-Danlos Syndrome Caused by BiallelicTNXBVariants in Patients with Congenital Adrenal Hyperplasia
32. Structural and Thermodynamic Characterization of Protein–Ligand Interactions Formed between Lipoprotein-Associated Phospholipase A2 and Inhibitors
33. Structure-Based Discovery of PDEs Inhibitors
34. A Dynamic View of ATP-coupled Functioning Cycle of Hsp90 N-terminal Domain
35. Thermodynamic and Structural Characterization of Halogen Bonding in Protein–Ligand Interactions: A Case Study of PDE5 and Its Inhibitors
36. Transforming Growth Factor-β and Inflammation in Vascular (Type IV) Ehlers–Danlos Syndrome
37. Virtual Screening and Structure-Based Discovery of Indole Acylguanidines as Potent β-secretase (BACE1) Inhibitors
38. Fragment-Based Drug Discovery of 2-Thiazolidinones as Inhibitors of the Histone Reader BRD4 Bromodomain
39. Ehlers-Danlos Syndrome Caused by Biallelic TNXB Variants in Patients with Congenital Adrenal Hyperplasia.
40. Cyanobacterial Peptides as a Prototype for the Design of Potent β-Secretase Inhibitors and the Development of Selective Chemical Probes for Other Aspartic Proteases
41. In Reply
42. Junction Site Analysis of Chimeric CYP21A1P/CYP21A2 Genes in 21-Hydroxylase Deficiency
43. Corrigendum to “No association between the promoter variants of tumor necrosis factor alpha (TNF-α) and schizophrenia in Chinese Han population” [Neurosci. Lett. 366 (2004) 139–143]
44. Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families
45. The phenotypic spectrum of contiguous deletion ofCYP21A2and tenascin XB: Quadricuspid aortic valve and other midline defects
46. Association between the PDE4D gene and ischaemic stroke in the Chinese Han population
47. An investigation of the dihydropyrimidinase-like 2 (DPYSL2) gene in schizophrenia: genetic association study and expression analysis
48. No association between the serotonin 1B receptor gene and schizophrenia in a case–control and family-based association study
49. No association between the promoter variants of tumor necrosis factor alpha (TNF-α) and schizophrenia in Chinese Han population
50. No association between the genetic polymorphisms within RTN4 and schizophrenia in the Chinese population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.